Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.
Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.
复制标题
DOI:
10.1158/0008-5472.can-12-3212
复制
发表时间:
2013-01-15
期刊:
影响因子:
11.2
通讯作者:
Rangnekar VM
中科院分区:
文献类型:
--
作者:
Burikhanov R;Shrestha-Bhattarai T;Qiu S;Shukla N;Hebbar N;Lele SM;Horbinski C;Rangnekar VM
Tumor suppressor PAR-4 acts in part by modulating sensitivity to apoptosis but the basis for its activity is not fully understood. In this study, we describe a novel mechanism of anti-apoptosis by NF-kappaB, revealing that it can block PAR-4-mediated apoptosis by downregulating trafficking of the PAR-4 receptor GRP78 from the endoplasmic reticulum (ER) to the cell surface. Mechanistic investigations revealed that NF-kappaB mediated this anti-apoptotic mechanism by upregulating expression of UACA, a pro-inflammatory protein in certain disease settings. In clinical specimens of cancer, a strong correlation existed between NF-kappaB activity and UACA expression, relative to normal tissues. UACA bound to intracellular PAR-4 in diverse cancer cells, where it prevented translocation of GRP78 from the ER to the cell surface. This pathway of anti-apoptosis could be inhibited by suppressing levels of NF-kappaB or UACA expression, which enhanced ER stress and restored GRP78 trafficking to the cell surface, thereby sensitizing cancer cells to apoptosis by extracellular PAR-4 or GRP78 agonistic antibody. In summary, our results identify a novel intracellular pathway of apoptosis mediated by NF-kappaB through UACA elevation, which by attenuating ER stress and GRP78 translocation to the cell surface can blunt the sensitivity of cancer cells to apoptosis.